1. Home
  2. NOC vs REGN Comparison

NOC vs REGN Comparison

Compare NOC & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northrop Grumman Corporation

NOC

Northrop Grumman Corporation

N/A

Current Price

$479.55

Market Cap

71.9B

Sector

Industrials

ML Signal

N/A

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

N/A

Current Price

$745.07

Market Cap

81.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NOC
REGN
Founded
1939
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.9B
81.1B
IPO Year
2002
1995

Fundamental Metrics

Financial Performance
Metric
NOC
REGN
Price
$479.55
$745.07
Analyst Decision
Buy
Buy
Analyst Count
26
27
Target Price
$623.00
★ $859.04
AVG Volume (30 Days)
★ 770.2K
597.3K
Earning Date
10-20-2026
10-30-2026
Dividend Yield
★ 2.04%
0.51%
EPS Growth
2.61
★ 8.19
EPS
13.83
★ 18.95
Revenue
★ $41,954,000,000.00
$5,872,227,000.00
Revenue This Year
$5.01
$20.04
Revenue Next Year
$6.65
$7.66
P/E Ratio
★ $35.03
$39.03
Revenue Growth
2.24
★ 20.82
52 Week Low
$471.36
$541.00
52 Week High
$774.00
$859.34

Technical Indicators

Market Signals
Indicator
NOC
REGN
Relative Strength Index (RSI) 34.14 41.28
Support Level $479.02 $732.04
Resistance Level $560.42 $779.86
Average True Range (ATR) 9.68 20.37
MACD -1.32 -3.45
Stochastic Oscillator 13.56 24.71

Price Performance

Historical Comparison
NOC
REGN

About NOC Northrop Grumman Corporation

Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment produces autonomous and piloted aircraft such as Global Hawk drones and the B-21 bomber, creates the fuselage for the massive F-35 program, and maintains and upgrades numerous other military aircraft. Defense systems makes artillery and missile ammunition and guidance systems, long-range missiles, and missile defense systems. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and rocket motors.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; Kevzara in rheumatoid arthritis; and Lynozyfic for multiple myeloma. Regeneron has multiple partnerships and collaboration agreements, with Sanofi (Dupixent, others) and Bayer (Eylea) as its largest partners.

Share on Social Networks: